D05.81

Clinical Causes: Genetic mutations that affect breast cell regulation Hormonal imbalances, particularly involving estrogen and progesterone Lifestyle factors such as alcohol consumption or inactivity Radiation exposure to the chest area History of previous breast abnormalities or surgeries Family history of breast cancer or carcinoma in situ

Key Symptoms: Often asymptomatic and discovered during routine screening mammograms Presence of microcalcifications detected via imaging Palpable lump may sometimes be felt but is uncommon Changes in breast skin or nipple are rare in early stages Nipple discharge or skin changes can occur if the condition progresses

Diagnosis Path: Diagnosis typically involves a combination of imaging and tissue sampling. Healthcare providers usually recommend the following steps: - Digital mammography to identify suspicious areas such as microcalcifications - Ultrasound or MRI if needed for detailed imaging - Biopsy (core needle or surgical biopsy) to obtain tissue samples for histopathological examination - Pathological analysis confirms the presence of non-invasive carcinoma confined within ducts or lobules and characterizes its specific type - Additional tests may include receptor status assessments (e.g., estrogen and progesterone receptors) to guide treatment planning

Treatment Protocols: Treatment strategies aim to remove the abnormal cells and prevent progression to invasive cancer. Options currently include: - Surgical excision such as lumpectomy or excisional biopsy, tailored to the size and location of the lesion - Radiation therapy to eliminate residual abnormal cells within the breast tissue - In some cases, systemic therapy like hormone therapy may be considered if hormone receptors are positive - Active surveillance with regular imaging and clinical follow-up for selected cases, especially if the lesions are small and low risk - The choice of treatment depends on various factors, including patient health, lesion characteristics, and overall risk assessment